Invention Grant
US06949546B2 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
有权
N-脲基杂环烷基 - 哌啶作为趋化因子受体活性的调节剂
- Patent Title: N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
- Patent Title (中): N-脲基杂环烷基 - 哌啶作为趋化因子受体活性的调节剂
-
Application No.: US10617303Application Date: 2003-07-10
-
Publication No.: US06949546B2Publication Date: 2005-09-27
- Inventor: Soo S. Ko , James R. Pruitt , Dean A. Wacker , Douglas G. Batt
- Applicant: Soo S. Ko , James R. Pruitt , Dean A. Wacker , Douglas G. Batt
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Pharma Company
- Current Assignee: Bristol-Myers Squibb Pharma Company
- Current Assignee Address: US NJ Princeton
- Agent Mary VanAtten
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; A61K31/5377 ; A61P11/00 ; A61P11/02 ; A61P11/06 ; A61P17/00 ; A61P29/00 ; A61P31/18 ; A61P35/00 ; A61P37/06 ; A61P43/00 ; C07D211/56 ; C07D211/58 ; C07D211/60 ; C07D211/62 ; C07D211/96 ; C07D401/14 ; C07D405/06 ; C07D405/14 ; C07D409/06 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; A61K31/4525
Abstract:
The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
Public/Granted literature
- US20040058961A1 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity Public/Granted day:2004-03-25
Information query
IPC分类:
